You are welcome to send your RFP, feasibility questionnaire or other request at info@mt.clinic

    «BioEq» recruits for patients to participate in a phase III clinical study in NSCLC.

    Study medication: anti-PD-L monoclonal antibody.

    We invite adult male and female patients. You can request any additional information by phone.

    Please contact us at 8-812-945-22-32 to learn more.

    Write a Reply or Comment

    Your email address will not be published. Required fields are marked *